Home/Filings/4/0001062993-24-003235
4//SEC Filing

Kieffer Tara Lynn 4

Accession 0001062993-24-003235

CIK 0001177648other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 8:21 PM ET

Size

6.5 KB

Accession

0001062993-24-003235

Insider Transaction Report

Form 4
Period: 2024-02-12
Kieffer Tara Lynn
Chief Product Strategy Officer
Transactions
  • Award

    Common Stock

    2024-02-12+3,32040,580 total
  • Tax Payment

    Common Stock

    2024-02-12$12.41/sh973$12,07539,607 total
Footnotes (2)
  • [F1]Represents shares of Enanta common stock issued under performance share units ("PSUs") that vested as a result of performance against two-year research and development milestones in the calendar 2022-2023 period as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2024.
  • [F2]Represents the number of shares of common stock automatically forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU awards.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1
  • filerCIK 0001834835

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:21 PM ET
Size
6.5 KB